New drug combo aims to control ovarian cancer in phase 2 trial
NCT ID NCT07059845
First seen Nov 03, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tests a new drug called mirvetuximab soravtansine, combined with either carboplatin or bevacizumab, in people with a specific type of ovarian cancer. About 320 participants will receive different doses to see which works best and is safest. The goal is to control the disease and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Hospital /ID# 276534
RECRUITINGMelbourne, Victoria, 3084, Australia
-
Burnside War Memorial Hospital /ID# 277602
RECRUITINGAdelaide, South Australia, 5065, Australia
-
Icon Cancer Centre Hobart /ID# 277688
RECRUITINGHobart, Tasmania, 7000, Australia
-
Icon Cancer Centre Wesley /ID# 277199
RECRUITINGAuchenflower, Queensland, 4066, Australia
-
Korea University Guro Hospital /ID# 276194
RECRUITINGSeoul, Seoul Teugbyeolsi, 08308, South Korea
-
Monash Health - Monash Medical Centre /ID# 276984
RECRUITINGClayton, Victoria, 3168, Australia
-
Samsung Medical Center /ID# 276261
RECRUITINGSeoul, Seoul Teugbyeolsi, 06351, South Korea
-
Seoul National University Hospital /ID# 276182
RECRUITINGSeoul, Seoul Teugbyeolsi, 03080, South Korea
-
St. George Private Hospital /ID# 276570
RECRUITINGKogarah, New South Wales, 2217, Australia
-
Yonsei University Health System Severance Hospital /ID# 276266
RECRUITINGSeoul, Seoul Teugbyeolsi, 03722, South Korea
Conditions
Explore the condition pages connected to this study.